Lanean...
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
PURPOSE: To investigate risk factors for severe bleeding during warfarin treatment, including the influence of sex, age, comorbidity and co-medication on bleeding risk. METHODS: Patients initiating warfarin treatment between 2007 and 2011 were identified in the nationwide Swedish Prescribed Drug Reg...
Gorde:
| Argitaratua izan da: | Eur J Clin Pharmacol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239828/ https://ncbi.nlm.nih.gov/pubmed/32222786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-020-02856-6 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|